# CARBIDOPA AND LEVODOPA
> **ANDA220119** · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA LIMITED · Approved 2025-12-04
## Drug
- **FDA Application Number:** ANDA220119
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CARBIDOPA AND LEVODOPA
- **Generic name:** Carbidopa,Levodopa
- **Active ingredients:** CARBIDOPA,LEVODOPA
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** BIOCON PHARMA LIMITED
- **First approval:** 2025-12-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220119)
---
*AI Analytics · CC0 1.0*